Bosch A, McCray P B, Chang S M, Ulich T R, Simonet W S, Jolly D J, Davidson B L
Department of Internal Medicine, University of Iowa, Iowa City 52242, USA.
J Clin Invest. 1996 Dec 15;98(12):2683-7. doi: 10.1172/JCI119091.
Retroviral gene transfer to liver without prior injury has not yet been accomplished. We hypothesized that recombinant human keratinocyte growth factor would stimulate proliferation of hepatocytes and allow for efficient in vivo gene transfer with high titer murine Moloney retroviral vectors. This report shows that 48 h after intravenous injection of keratinocyte growth factor, hepatocyte proliferation increased approximately 40-fold compared to non-stimulated livers. When keratinocyte growth factor treatment was followed by intravenous injection of high titer (1 x 10(8) colony forming units/ml) retrovirus coding for the Escherichia Coli beta-galactosidase gene, there was a 600-fold increase in beta-galactosidase expression, with 2% of hepatocytes transduced. Thus, by exploiting the mitogenic properties of keratinocyte growth factor, retrovirus-mediated gene transfer to liver may be accomplished in vivo without the use of partial hepatectomy or pretreatment with other toxins to induce hepatocyte cell division.
在没有预先损伤的情况下,将逆转录病毒基因导入肝脏尚未实现。我们推测重组人角质形成细胞生长因子会刺激肝细胞增殖,并允许使用高滴度鼠莫洛尼逆转录病毒载体进行高效的体内基因转移。本报告显示,静脉注射角质形成细胞生长因子48小时后,与未受刺激的肝脏相比,肝细胞增殖增加了约40倍。当在角质形成细胞生长因子处理后静脉注射编码大肠杆菌β-半乳糖苷酶基因的高滴度(1×10⁸集落形成单位/毫升)逆转录病毒时,β-半乳糖苷酶表达增加了600倍,2%的肝细胞被转导。因此,通过利用角质形成细胞生长因子的促有丝分裂特性,无需进行部分肝切除或用其他毒素预处理来诱导肝细胞分裂,就可以在体内实现逆转录病毒介导的基因向肝脏的转移。